Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong · Delayed Price · Currency is HKD 14.61
-0.05 (-0.34%)
Nov 11, 2026, 3:43 PM HKT
Qyuns Therapeutics Market Cap
Qyuns Therapeutics has a market cap or net worth of 3.26 billion as of November 10, 2026. It is the 15,781st most valuable company in the world and the 705th biggest in Hong Kong. Its market cap has decreased by 25.08% in one year.
Market Cap
3.26B
Enterprise Value
2.83B
Revenue
1.18B
Global Rank
Country Rank
#705 Hong Kong
PE Ratio
5.21
ChartMarket Cap Chart
Since March 20, 2024, Qyuns Therapeutics's market cap has decreased from 5.02B to 3.26B, a decrease of -34.94%. That is a compound annual growth rate of -14.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 3.26B | -22.96% |
| Dec 31, 2025 | 4.24B | 158.47% |
| Dec 31, 2024 | 1.64B | -67.33% |
| Mar 20, 2024 | 5.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hanx Biopharmaceuticals (Wuhan) | 3.68B |
| Mirxes Holding Company | 3.66B |
| Jacobio Pharmaceuticals Group | 3.65B |
| TenNor Therapeutics (Suzhou) | 3.45B |
| TransThera Sciences (Nanjing) | 3.29B |
| Beijing Luzhu Biotechnology | 3.06B |
| Frontage Holdings | 3.03B |
| Shanghai Bao Pharmaceuticals | 2.84B |